Evidence Building
How to Present Patent Application Records as O-1A Original Contributions Evidence Before Grant Issuance
Patent applications pending at the USPTO create an evidence problem for the O-1A original contributions criterion. USCIS will not treat a pending application as a granted patent. This guide explains what documentation to gather and how to frame pre-grant records as major significance evidence.
The original contributions criterion and pending patent timing
The original contributions criterion under 8 C.F.R. § 214.2(o)(3)(ii)(C) requires evidence of original scientific, scholarly, or business-related contributions of major significance. For researchers and engineers who rely on patent evidence to meet this criterion, the pre-grant period creates a timing problem that many petitioners and practitioners underestimate. A patent application that has been filed but not yet issued is not a patent — it is a pending application that represents a claim to inventorship rather than a granted right. USCIS adjudicators will not treat a pending application the same as an issued patent, and a petition that presents only application records without understanding that distinction risks a response requesting confirmation of the patent's actual status and significance.
Many researchers file O-1A petitions while they have patent applications pending at the USPTO, because the timeline of a researcher's career does not always align with the multi-year examination cycle at the patent office. A first patent application filed by a researcher at the peak of their productive output may still be under examination when the career opportunity that requires O-1A status arrives. Filing the petition without addressing the pending status of the application directly leaves the adjudicator to infer significance from a document that facially establishes only that an application was submitted, not that it has been recognized as a significant contribution to the field.
The core challenge with pre-grant patent records is that the application itself does not speak to significance. A granted patent carries with it an implicit endorsement from a USPTO examiner that the claimed invention is novel, non-obvious, and useful under 35 U.S.C. §§ 102, 103, and 101. A pending application has received no such examination-based endorsement. USCIS adjudicators evaluating original contributions evidence are looking for indicators of significance beyond mere novelty — they want to see that the field recognizes the contribution as important. With a pending application, the petition must build that case for significance through accompanying evidence because the application record itself provides only the threshold showing that a contribution was made.
What the regulation requires for original contributions evidence
The regulatory text at 8 C.F.R. § 214.2(o)(3)(ii)(C) requires evidence of the alien's original scientific, scholarly, or business-related contributions of major significance in the field. The phrase "major significance" distinguishes this criterion from a simple novelty standard — USCIS interprets major significance to mean that the contribution has had, or is likely to have, a discernible impact on the field rather than merely representing incremental advancement. For patent-based claims, USCIS looks to evidence that the patented technology has been adopted, licensed, cited by others, or recognized by technical organizations as an advance of consequence. A pending application that will eventually mature into a granted patent can meet this standard if the petition documents the indicators of significance independently of the formal grant.
The USCIS Policy Manual confirms that the agency evaluates the totality of evidence rather than requiring any single document to establish significance. This totality approach is particularly important for pending patent applications, because no single document in a pre-grant record can substitute for the USPTO grant. Instead, the petition should assemble a combination of records: the published application (once published under 35 U.S.C. § 122(b), typically 18 months after the priority date), citations to the application in other researchers' work or in competing applications, any technology transfer office documentation of licensing negotiations or commercial interest, expert declarations from technically qualified individuals in the field explaining the significance of the claimed invention, and any press or industry coverage of the technology being developed.
Expert declarations play a particularly critical role in pre-grant original contributions evidence. Because the application record itself does not include an external endorsement of significance, the petition must supply that endorsement through the expert declaration. The declarant should be a researcher or practitioner with recognized expertise in the relevant technical field who can explain what the claimed invention does, why the approach is novel compared to prior art, and what impact the technology would have if commercialized or implemented at scale. An expert who has independently followed the development of the technology, reviewed the applicant's publications describing the underlying science, or worked in adjacent areas of the field provides the most persuasive form of pre-grant significance testimony.
Evidence that routinely supports pre-grant patent records
Published patent applications — those that have been published by the USPTO under the 18-month automatic publication rule — provide a more useful foundation than unpublished applications because they establish that the application has been formally submitted, assigned a serial number, and subjected to the preliminary review process that precedes examination. The published application number and the publication date are verifiable from the USPTO Patent Full-Text Database, and the application's published status confirms that it has at minimum survived the early procedural stages. From the published application, petitioners can extract the claims language, which describes with legal precision what the petitioner is claiming as their inventive contribution, and this claims language can be used by experts and the petitioner's attorney to frame the significance argument.
Continuation and divisional applications that share priority with the core application are useful supplementary records when they exist. If a researcher has built a patent family around a core inventive concept — filing continuations to extend claim coverage, divisionals to protect related but distinct aspects of the invention, or continuation-in-part applications to cover improvements developed after the original filing — that family structure demonstrates sustained investment in developing and protecting the inventive concept. A patent family with multiple pending applications sharing a common priority date is a stronger indicator of inventive significance than a single isolated application, even before any application in the family has been granted, because the family structure reflects judgments by the petitioner and their institution about the value of the underlying technology.
Office actions from the USPTO examination record, if examination has begun, are sometimes overlooked as O-1A evidence but can be helpful in specific contexts. An office action that identifies the closest prior art and explains the examiner's view of how the claimed invention relates to that prior art gives the petitioner's expert a concrete technical record to work with. If the office action acknowledges a novel aspect of the claim — even while imposing rejections under §§ 102 or 103 that the applicant intends to overcome — that acknowledgment can be cited in the expert declaration as the USPTO's own preliminary recognition of the inventive concept. An examiner's allowance following a response to office actions is the clearest indicator that the claimed invention has survived examination, and petitions that include an allowed application in prosecution history are in a substantially stronger position than those with only a filed application.
Evidence USCIS regularly discounts for pre-grant applications
The application itself, submitted without additional context, is the most commonly discounted form of pre-grant patent evidence. USCIS adjudicators reviewing a petition that presents a pending application number, a filing date, and perhaps an abstract are given no basis to assess significance — those documents establish only that the petitioner submitted an application, which is a routine step in any researcher's or engineer's career rather than evidence of major significance. Adjudicators who issue RFEs on original contributions evidence frequently cite the absence of any record demonstrating that the claimed invention has been recognized, adopted, cited, or otherwise acted upon by others in the field, and a bare application record invites exactly this response.
Self-referential documentation is particularly weak for pending applications. A declaration from the petitioner describing the significance of their own invention, without corroboration from technically qualified third parties who have independently reviewed the technology, does not carry the weight of an expert declaration. USCIS guidance consistently emphasizes the importance of testimony from recognized individuals in the field who can speak to the contribution from a position external to the petitioner's own research group. A petitioner who filed the application, who is named as the inventor on the application, and who also describes the application's significance in their own declaration is presenting evidence that the adjudicator will likely treat as cumulative of the application record itself.
Provisional applications present a specific evidentiary limitation that petitioners should understand. A provisional application establishes a priority date and allows the applicant to use the patent-pending designation, but provisionals are never examined, never published, and never mature into patents without the subsequent filing of a non-provisional application. Submitting a provisional application as original contributions evidence gives USCIS no technically meaningful record — provisionals do not disclose claims in the legal sense used in examination, they are not searchable in the published application database, and they expire after twelve months without creating any patent rights. If only a provisional has been filed, the petition should focus on the underlying research publications and technical disclosures that preceded the provisional filing rather than on the provisional itself.
How to frame borderline pre-grant evidence
The most effective framing for a pending patent in an O-1A petition places the application within the trajectory of a coherent body of work rather than presenting it as a standalone credential. A researcher who has published peer-reviewed articles describing the scientific basis for the claimed invention, received grant funding to develop the technology, and then filed a patent application to protect the commercial application of that research has built a narrative arc that the petition can follow: the contribution began in the published literature, was funded by a recognized federal agency, and is now being protected through the patent system because it has reached a stage of development that justifies commercial protection. That narrative is considerably more persuasive than an application presented in isolation.
Technology licensing correspondence and expressions of commercial interest from industry partners, even if preliminary, help bridge the gap between a pending application and the showing of major significance that USCIS requires. A letter of interest from a company describing why the technology addressed by the application is relevant to their product development, even a non-binding letter drafted in early-stage discussions with a technology transfer office, documents that the claimed invention has attracted external attention and been evaluated by parties with commercial stakes. The petition should explain the context of that interest — what the technology does, why the company considered it significant, and what the next steps in the licensing process might be — to give the adjudicator a basis to assess the significance of the external interest.
When the petitioner's institution has filed the application on the petitioner's behalf — as is standard practice at research universities where inventions made with institutional resources are subject to the institution's patent policy — a letter from the technology transfer office or general counsel's office explaining the institution's filing decision is a useful form of framing evidence. Technology transfer offices at research universities evaluate inventions before investing institutional resources in prosecution, and a letter from that office explaining that the institution evaluated the claimed invention and determined it was worth filing can serve as an institutional endorsement of the invention's significance that is external to the petitioner's own judgment about their work.
Building and auditing a pre-grant contributions file
A well-constructed original contributions exhibit for a pending patent application should contain the following records: the published application (or a USPTO status printout showing filing date, serial number, and current prosecution status for unpublished applications); the prosecution history summary, including any office actions and responses if examination is underway; a technology transfer office letter explaining the institution's filing decision; at least two expert declarations from technically qualified individuals in the field who are not co-inventors and who explain the significance of the claimed invention by reference to the prior art landscape; any citations of the application or underlying research in other parties' patent applications; and any correspondence from industry partners or licensees showing commercial interest in the technology.
The expert declarations in a patent-based original contributions file should satisfy several structural criteria. Each declarant should establish their technical qualifications in the relevant field before offering an opinion on the claimed invention's significance. The declaration should describe the state of the art before the petitioner's contribution — what the prior art disclosed, what problems it had not solved, or what capabilities it lacked — and then explain how the petitioner's invention advances beyond that baseline. The declaration should identify specific aspects of the claims that represent the inventive step and connect those aspects to the field impact that qualifies as major significance. Declarations that simply state that the invention is important, without technical grounding or prior-art context, will be treated by adjudicators as conclusory rather than probative.
Petitioners should audit the complete contributions exhibit before filing to confirm that each document is dated, identified by its source, and accompanied by a translation if it is in a language other than English. USPTO published applications are in English, but foreign counterpart applications filed in national patent offices — which can be included as supplementary evidence of the international scope of protection sought — may require certified translations. The audit should also confirm that the expert declarations do not disclose any confidential prosecution strategy and that the claims language cited in the declarations accurately reflects the current version of the claims, since claims are frequently amended during prosecution and a declaration describing superseded claim language will be read as internally inconsistent with the current application record.
What we typically gather for this kind of case
| Document | Where to source | Why it matters |
|---|---|---|
| Peer-reviewed publications | Web of Science / Scopus exports | Anchors original-contributions and authorship criteria |
| Citation analysis | Google Scholar profile + ESI top-1% data | Quantifies major significance in the field |
| Salary benchmark | BLS OEWS for SOC code + locality | Documents high-salary criterion at 90th-percentile or above |
| Critical-role letters | Direct supervisor + program director | Establishes role's importance, not just title |
What we see go wrong, again and again
- 01Treating extraordinary ability as a credentials checklist rather than a story of field-wide impact.
- 02Submitting bibliometric data (h-index, citation counts) without explaining what makes those numbers high relative to peers in the same sub-field.
- 03Relying on letters from collaborators or co-authors rather than independent experts who can speak to influence.
See if you qualify
Lando reviews your background against the O-1 visa criteria and tells you honestly where you stand. Free, no commitment.